s6y
Company name or ticker
Search
Propanc Biopharma, Inc.
DEF 14C
Definitive information statements
Filed
Wednesday, October 21, 2026
Period
Oct 20, 2026
Accession number
0001493152-26-047806
Documents
DEF 14C
DEF 14C
On sec.gov
Filing index
All files
Complete submission text
SGML header